NEW YORK (GenomeWeb) – Investment bank Bloom Burton & Co. is proving funding to Ontario-based personalized health firm Newtopia, the company announced today.

Bloom Burton's support follows the announcement in October that the international insurance underwriter Argo Group US will invest in Newtopia and use the company's personalized medicine services across its US employee base to reduce corporate healthcare costs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.